Pfizer Recalls Blood Pressure Drug Accuretic Due To Potential Carcinogen
NEW YORK — Pfizer Inc. on March 21 voluntarily recalled certain lots of its blood pressure drug Accuretic (quinapril) and two authorized generic versions due to the presence of potentially cancer-causing...To view the full article, register now.
Already a subscriber? Click here to view full article